enhancer drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| rs1409568 | associated_with | enhancer | — | 1 |
Mentioned in (12)
Papers in which this entity is mentioned.
- Annotating the genome at single-nucleotide resolution with DNA foundation models. (2025)
- Nucleotide Transformer: building and evaluating robust foundation models for human genomics. (2025)
- Transcription start sites experience a high influx of heritable variants fueled by early development. (2025)
- PEREGRINE: A genome-wide prediction of enhancer to gene relationships supported by experimental evidence. (2020)
- Transcriptomic signatures across human tissues identify functional rare genetic variation. (2020)
- Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
- Genome-wide association study identifies a novel locus for cannabis dependence. (2018)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
- Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. (2016)
- MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. (2014)
- Landscape of transcription in human cells. (2012)
- An integrated encyclopedia of DNA elements in the human genome. (2012)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| enhancer | drug | 15 | 20 |
| enhancers | drug | 12 | 13 |
| active enhancers | drug | 3 | 3 |
| active enhancer | drug | — | — |